GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Chunlizhengda Medical Instruments Co Ltd (HKSE:01858) » Definitions » Additional Paid-In Capital

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Additional Paid-In Capital : HK$1,140.8 Mil(As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Chunlizhengda Medical Instruments Co Additional Paid-In Capital?


Beijing Chunlizhengda Medical Instruments Co's quarterly additional paid-in capital declined from Jun. 2023 (HK$1,140.8 Mil) to Sep. 2023 (HK$0.0 Mil) but then increased from Sep. 2023 (HK$0.0 Mil) to Dec. 2023 (HK$1,140.8 Mil).

Beijing Chunlizhengda Medical Instruments Co's annual additional paid-in capital declined from Dec. 2021 (HK$1,285.0 Mil) to Dec. 2022 (HK$1,171.9 Mil) and declined from Dec. 2022 (HK$1,171.9 Mil) to Dec. 2023 (HK$1,140.8 Mil).


Beijing Chunlizhengda Medical Instruments Co Additional Paid-In Capital Historical Data

The historical data trend for Beijing Chunlizhengda Medical Instruments Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Chunlizhengda Medical Instruments Co Additional Paid-In Capital Chart

Beijing Chunlizhengda Medical Instruments Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 253.97 24.57 1,284.99 1,171.91 1,140.81

Beijing Chunlizhengda Medical Instruments Co Quarterly Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,171.91 1,140.81 - 1,140.81 -

Beijing Chunlizhengda Medical Instruments Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Beijing Chunlizhengda Medical Instruments Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Beijing Chunlizhengda Medical Instruments Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Business Description

Traded in Other Exchanges
Address
No. 10 Xinmi Xi Er Road, Southern District of Tongzhou, Economic Development Zone, Tongzhou District, Beijing, CHN
Beijing Chunlizhengda Medical Instruments Co Ltd is an orthopedic medical device company. It is engaged in the research, development, manufacture, and sale of orthopedic medical devices, including joint prosthesis products and spinal products. The products offered by the company are classified into three categories, namely Standard joint prosthesis products, Custom joint prosthesis products, and Spinal products. It operates in the business segment of manufacture and trading of surgical implants, instruments and related products.
Executives
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co. 2502 Approved lending agent
Citigroup Inc. 2502 Approved lending agent
Fidelity China Special Situations Plc 2101 Beneficial owner
Taiping Assets Management (hk) Company Limited 2102 Investment manager
Taiping Trustees Limited 2301 Trustee

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Headlines

No Headlines